GPT and metabolic dysfunction-associated steatotic liver disease: Some RCTs reported no significant impact of consuming products containing ACNs on ALT levels in healthy postmenopausal women (Curtis et al., 2009), patients with pre‐diabetes (Yang, Ling, Yang, et al., 2017), diabetes (Mohtashami et al., 2019; Soltani et al., 2015; Yang, Ling, Yang, et al., 2017), NAFLD (Chang et al., 2014), and hyperlipidemia (Kianbakht et al., 2014; Soltani et al., 2014).